诺华-investor-presentation-jpm-2025-growth-story.pdf

1、Novartisgrowth storyVas Narasimhan,CEOJ.P.Morgan Healthcare ConferenceJanuary 14,2025Disclaimer2This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995,that can generally be identified by words such as“potential,”

2、“expected,”“will,”“planned,”“pipeline,”“outlook,”“confident,”or similar expressions,or by express or implied discussions regarding potential new products,potential new indications for existing products,potential product launches,or regarding potential future revenues from any such products;or regard

3、ing results of ongoing clinical trials;or regarding potential future,pending or announced transactions;regarding potential future sales or earnings;or by discussions of strategy,plans,expectations or intentions,including discussions regarding our continued investment into new R&D capabilities and ma

4、nufacturing;or regarding our capital structure;or regarding the consequences of the spin-off of Sandoz and our transformation into a“pure-play”innovative medicines company.Such forward-looking statements are based on the current beliefs and expectations of management regarding future events and are

5、subject to significant known and unknown risks and uncertainties.Should one or more of these risks or uncertainties materialize,or should underlying assumptions prove incorrect,actual results may vary materially from those set forth in the forward-looking statements.You should not place undue relian

6、ce on these statements.There can be no guarantee that the investigational or approved products described in this presentation will be submitted or approved for sale or for any additional indications or labeling in any market,or at any particular time.Nor can there be any guarantee that such products